1.Kanis JA., Oden A., Johansson H., Borgstrom F., Strom O., McCloskey E. FRAX and its applications to clinical practice. Bone. 2009. 44:734–43.
Article
2.Han M. Metabolic Syndrome Emerging from Menopause. J Korean Soc Menopause. 2011. 17:127–35.
Article
3.Hofbauer LC., Schoppet M. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA. 2004. 292:490–5.
Article
4.Khosla S., Riggs BL. Pathophysiology of age-related bone loss and osteoporosis. Endocrinol Metab Clin North Am. 2005. 34:1015–30. xi.
Article
5.Lee DH., Blomhoff R., Jacobs DR Jr. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radic Res. 2004. 38:535–9.
6.Strasak AM., Rapp K., Brant LJ., Hilbe W., Gregory M., Oberaigner W, et al. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res. 2008. 68:3970–7.
7.Ryu S., Chang Y., Kim DI., Kim WS., Suh BS. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007. 53:71–7.
8.Lim J., Kim S., Ke S., Cho B. The Prevalence of Obesity, Abdominal Obesity and Metabolic Syndrome among Elderly in General Population. Korean J Fam Med. 2011. 32:128–34.
Article
9.Sheng Z., Xu K., Ou Y., Dai R., Luo X., Liu S, et al. Relationship of body composition with prevalence of osteoporosis in central south Chinese postmenopausal women. Clin Endocrinol (Oxf). 2011. 74:319–24.
Article
10.Lee JY., Jeong KA., Cha YJ., Kim HY. The Relationship between Body Composition, Serum Lipid Profile and Bone Mineral Density in Korean Women. Osteoporosis. 2009. 7:159–67.
11.Douchi T., Yamamoto S., Oki T., Maruta K., Kuwahata R., Nagata Y. Relationship between body fat distribution and bone mineral density in premenopausal Japanese women. Obstet Gynecol. 2000. 95:722–5.
Article
12.Sowers MF., Kshirsagar A., Crutchfield MM., Updike S. Joint influence of fat and lean body composition compartments on femoral bone mineral density in premenopausal women. Am J Epidemiol. 1992. 136:257–65.
Article
13.Oh HJ., Jeong MH., Kim HY., Oh JY., Jung JY., Kim MH, et al. The Effect of Hormone Replacement Therapy on Bone Mineral Density in Korean Postmenopausal Women for 2 Years. Osteoporosis. 2009. 7:35–42.
14.Salim A., Nacamuli RP., Morgan EF., Giaccia AJ., Longaker MT. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem. 2004. 279:40007–16.
Article
15.Arnett TR., Gibbons DC., Utting JC., Orriss IR., Hoebertz A., Rosendaal M, et al. Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol. 2003. 196:2–8.
Article
16.Galli F., Piroddi M., Annetti C., Aisa C., Floridi E., Floridi A. Oxidative stress and reactive oxygen species. Contrib Nephrol. 2005. 149:240–60.
Article
17.Altindag O., Erel O., Soran N., Celik H., Selek S. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol Int. 2008. 28:317–21.
Article
18.Basu S., Michaëlsson K., Olofsson H., Johansson S., Melhus H. Association between Oxidative Stress and Bone Mineral Density. Biochem Biophys Res Commun. 2001. 288:275–9.
Article
19.Garrett IR., Boyce BF., Oreffo RO., Bonewald L., Poser J., Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest. 1990. 85:632–9.
Article
20.Dreher I., Schutze N., Baur A., Hesse K., Schneider D., Kohrle J, et al. Selenoproteins are expressed in fetal human osteoblast-like cells. Biochem Biophys Res Commun. 1998. 245:101–7.
Article
21.Sontakke AN., Tare RS. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta. 2002. 318:145–8.
Article
22.Maggio D., Barabani M., Pierandrei M., Polidori MC., Catani M., Mecocci P, et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab. 2003. 88:1523–7.
Article
23.Borud O., Mortensen B., Mikkelsen IM., Leroy P., Wellman M., Huseby NE. Regulation of gamma-glutamyltransferase in cisplatin-resistant and -sensitive colon carcinoma cells after acute cisplatin and oxidative stress exposures. Int J Cancer. 2000. 88:464–8.
24.Lee DH., Jacobs DRJ., Gross M., Kiefe CI., Roseman J., Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in young adults (CARDIA) study. Clin Chem. 2003. 49:1358–66.
25.Allen JP., Litten RZ., Fertig JB., Sillanaukee P. Carbohydrate-deficient transferrin, gamma-glutamyltransferase, and macrocytic volume as biomarkers of alcohol problems in women. Alcohol Clin Exp Res. 2000. 24:492–6.
Article
26.Iwasaki T., Yoneda M., Kawasaki S., Fujita K., Nakajima A., Terauchi Y. Hepatic fat content-independent association of the serum level of gamma-glutamyltransferase with visceral adiposity, but not subcutaneous adiposity. Diabetes Res Clin Pract. 2008. 79:e13–4.
Article
27.Verrijken A., Francque S., Mertens I., Talloen M., Peiffer F., Van Gaal L. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. Int J Obes (Lond). 2010. 34:899–907.
Article
28.Yamada J., Tomiyama H., Yambe M., Koji Y., Motobe K., Shiina K, et al. Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome. Atherosclerosis. 2006. 189:198–205.
Article
29.Yu MA., Sanchez-Lozada LG., Johnson RJ., Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens. 2010. 28:1234–42.
Article
30.Glantzounis GK., Tsimoyiannis EC., Kappas AM., Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005. 11:4145–51.
Article
31.Bonora E., Capaldo B., Perin PC., Del Prato S., De Mattia G., Frittitta L, et al. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis. 2008. 18:624–31.
Article
32.Lippi G., Montagnana M., Luca Salvagno G., Targher G., Cesare Guidi G. Epidemiological association between uric acid concentration in plasma, lipoprotein(a), and the traditional lipid profile. Clin Cardiol. 2010. 33:E76–80.
Article
33.Machin M., Simoyi MF., Blemings KP., Klandorf H. Increased dietary protein elevates plasma uric acid and is associated with decreased oxidative stress in rapidly-growing broilers. Comp Biochem Physiol B Biochem Mol Biol. 2004. 137:383–90.